Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Summer sweeteners

How biotechs tapping the market are sweetening their deal terms

Biotechs looking to tap the markets are sweetening their deal terms with deep discounts or bells and whistles such as warrants. The goal is to entice the handful of buysiders shopping for bargains because they see little upside for the sector until after the U.S. presidential election in November.

This year,

Read the full 512 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers